FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Thomas Patterson

Research Profile

Chemicals & Drugs

Disorders

Procedures

Microbial Sensitivity Tests

Living Beings

Physiology

Co-author Network

Publications

TOP 3
Steven D Westbrook; Nathan Wiederhold; JUAN TORO; Cesar O Freytes; William R Kirkpatrick; Thomas Patterson; Spencer Redding
Microbiology and epidemiology of oral yeast colonization in hemopoietic progenitor cell transplant recipients.
Nathan Wiederhold; Rosie Bocanegra; William R Kirkpatrick; Laura K Najvar; Thomas Patterson; Christopher R Thornton
Interlaboratory and interstudy reproducibility of a novel lateral-flow device and influence of antifungal therapy on detection of invasive pulmonary aspergillosis.
Nathan Wiederhold; Tania C Sorrell; Rosie Bocanegra; William R Kirkpatrick; Laura K Najvar; Thomas Patterson
Limited activity of miltefosine in murine models of cryptococcal meningoencephalitis and disseminated cryptococcosis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Thomas Patterson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Steven D Westbrook; Nathan Wiederhold; JUAN TORO; Cesar O Freytes; William R Kirkpatrick; Thomas Patterson; Spencer Redding
Microbiology and epidemiology of oral yeast colonization in hemopoietic progenitor cell transplant recipients.
Oral surgery, oral medicine, oral pathology and oral radiology 2013;115(3):354-8.
2013: Nathan Wiederhold; Rosie Bocanegra; William R Kirkpatrick; Laura K Najvar; Thomas Patterson; Christopher R Thornton
Interlaboratory and interstudy reproducibility of a novel lateral-flow device and influence of antifungal therapy on detection of invasive pulmonary aspergillosis.
Journal of clinical microbiology 2013;51(2):459-65.
2013: Nathan Wiederhold; Tania C Sorrell; Rosie Bocanegra; William R Kirkpatrick; Laura K Najvar; Thomas Patterson
Limited activity of miltefosine in murine models of cryptococcal meningoencephalitis and disseminated cryptococcosis.
Antimicrobial agents and chemotherapy 2013;57(2):745-50.
2013: John W Baddley; Michael Boeckh; Kyle D Brizendine; Tom M Chiller; James I Ito; Carol A Kauffman; Dimitrios P Kontoyiannis; G Marshall Lyon; Kieren Marr; Robert A Oster; Thomas Patterson; Mindy G Schuster; David Andes; Peter G Pappas
Antifungal therapy and length of hospitalization in transplant patients with invasive aspergillosis.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2013;51(2):128-35.
2012: George R Thompson; Nathan Wiederhold; Rosie Bocanegra; John Graybill; William R Kirkpatrick; Laura K Najvar; Thomas Patterson
A murine model of Cryptococcus gattii meningoencephalitis.
The Journal of antimicrobial chemotherapy 2012;67(6):1432-8.
2012: William R Kirkpatrick; Alan R Kugler; Laura K Najvar; Kimberly Perkins; Juergen Pfeiffer; Theresa D Sweeney; Ana C Vallor; Nathan Wiederhold; Rosie Bocanegra; Thomas Patterson
Prophylactic efficacy of single dose pulmonary administration of amphotericin B inhalation powder in a guinea pig model of invasive pulmonary aspergillosis.
The Journal of antimicrobial chemotherapy 2012;67(4):970-6.
2012: Martina Lengerova; Jiri Mayer; Laura K Najvar; Kristyna Hrncirova; William R Kirkpatrick; Iva Kocmanova; Sarka Pospisilova; Zdenek Racil; Nathan Wiederhold; Thomas Patterson
Detection and measurement of fungal burden in a guinea pig model of invasive pulmonary aspergillosis by novel quantitative nested real-time PCR compared with galactomannan and (1,3)-β-D-glucan detection.
Journal of clinical microbiology 2012;50(3):602-8.
2012: Nathan Wiederhold; Rosie Bocanegra; William R Kirkpatrick; Laura K Najvar; Thomas Patterson
Comparison of anidulafungin's and fluconazole's in vivo activity in neutropenic and non-neutropenic models of invasive candidiasis.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2012;18(2):E20-3.
2012: Payal K Patel; Deborah K Berg; John Cornell; Joshua E Erlandsen; William R Kirkpatrick; Christopher Louden; Spencer Redding; George R Thompson; Ana C Vallor; Steven D Westbrook; Brian L Wickes; Nathan Wiederhold; Thomas Patterson
The Changing Epidemiology of Oropharyngeal Candidiasis in Patients with HIV/AIDS in the Era of Antiretroviral Therapy.
AIDS research and treatment 2012;2012():262471.
2012: Simon F Dufresne; Marta Feldmesser; Xinming Li; Ekaterina Dadachova; Kausik Datta; Thomas Patterson; Janet F. Staab; Kieren Marr
Detection of urinary excreted fungal galactomannan-like antigens for diagnosis of invasive aspergillosis.
PloS one 2012;7(8):e42736.
2012: Dennis G Hooper; William R Kirkpatrick; Laura K Najvar; Vincent E Bolton; Frederick T Guilford; David C Straus; John S Sutton; Nathan Wiederhold; Thomas Patterson
Assessment of Aspergillus fumigatus in Guinea Pig Bronchoalveolar Lavages and Pulmonary Tissue by Culture and Realtime Polymerase Chain Reaction Studies.
International journal of molecular sciences 2012;13(1):726-36.
2011: Benjamin Park; Thomas Patterson; Trish M Perl; Mindy G Schuster; Randall Walker; THOMAS WALSH; Kathleen A Wannemuehler; John R Wingard; Barbara D Alexander; Elias J Anaissie; David R Andes; John W Baddley; Janice M Brown; Lisa M Brumble; Alison G Freifeld; Susan Hadley; Loreen A Herwaldt; James I Ito; Carol A Kauffman; G Marshall Lyon; Kieren Marr; Vicki A Morrison; Genovefa Papanicolaou; Peter G Pappas; Dimitrios P Kontoyiannis
Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006.
Emerging infectious diseases 2011;17(10):1855-64.
2011: Nathan Wiederhold; Rosie A Bocanegra; William R Kirkpatrick; Laura K Najvar; Thomas Patterson
Caspofungin dose escalation for invasive candidiasis due to resistant Candida albicans.
Antimicrobial agents and chemotherapy 2011;55(7):3254-60.
2011: Michael J Brumlik; Standwell Nkhoma; Mark J Kious; George R Thompson; Thomas Patterson; John J Siekierka; Timothy JC Anderson; Tyler J Curiel
Human p38 mitogen-activated protein kinase inhibitor drugs inhibit Plasmodium falciparum replication.
Experimental parasitology 2011;128(2):170-5.
2011: Luis Ostrosky-Zeichner; Bart Jan Kullberg; Eric J Bow; Susan Hadley; Cristóbal León; Marcio Nucci; Thomas Patterson; John R Perfect
Early treatment of candidemia in adults: a review.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2011;49(2):113-20.
2011: Thomas Patterson
Clinical utility and development of biomarkers in invasive aspergillosis.
Transactions of the American Clinical and Climatological Association 2011;122():174-83.
2010: J W Hiemenz; I I Raad; J A Maertens; R Y Hachem; A J Saah; C A Sable; J A Chodakewitz; M E Severino; P Saddier; R S Berman; D M Ryan; M J Dinubile; Thomas Patterson; D W Denning; THOMAS WALSH
Efficacy of caspofungin as salvage therapy for invasive aspergillosis compared to standard therapy in a historical cohort.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2010;29(11):1387-94.
2010: Federico Palacio-Bedoya; Jose A Cadena; George R Thompson; Deanna A Sutton; Aaron D Owens; Thomas Patterson
A noninvasive renal fungus ball caused by Rhizopus--a previously unreported manifestation of zygomycosis.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2010;48(6):866-9.
2010: William R Kirkpatrick; Joseph D Zimmerman; Fadi P Haikal; Michael J Broker; Erin Brockway; Annette W Fothergill; Dora I McCarthy; Thomas Patterson; Spencer Redding
Screening for drug-resistant Candida yeasts with chromogenic agar.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2010;48(6):807-16.
2010: John W Baddley; David Andes; Kieren Marr; Dimitrios P Kontoyiannis; Barbara D Alexander; Carol A Kauffman; Robert A Oster; Elias J Anaissie; THOMAS WALSH; Mindy G Schuster; John R Wingard; Thomas Patterson; James I Ito; O Dale Williams; Tom Chiller; Peter G Pappas
Factors associated with mortality in transplant patients with invasive aspergillosis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010;50(12):1559-67.
2010: Steven D Westbrook; Nathan Wiederhold; Ana C Vallor; Susann Kotara; Stella Bernardo; Samuel A Lee; William R Kirkpatrick; JUAN TORO; Cesar O Freytes; Thomas Patterson; Spencer Redding
Loss of in vitro resistance in Candida glabrata following discontinuation of fluconazole prophylaxis in a hematopoietic stem cell transplantation patient.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2010;48(3):557-60.
2010: Natalie E Nierenberg; George R Thompson; James S Lewis; Brian K Hogan; Thomas Patterson
Voriconazole use and pharmacokinetics in combination with interferon-gamma for refractory cryptococcal meningitis in a patient receiving low-dose ritonavir.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2010;48(3):532-6.
2010: Dimitrios P Kontoyiannis; Kieren Marr; Benjamin Park; Barbara D Alexander; Elias J Anaissie; THOMAS WALSH; James Ito; David R Andes; John W Baddley; Janice M Brown; Lisa M Brumble; Alison G Freifeld; Susan Hadley; Loreen A Herwaldt; Carol A Kauffman; Katherine Knapp; G Marshall Lyon; Vicki A Morrison; Genovefa A Papanicolaou; Thomas Patterson; Trish M Perl; Mindy G Schuster; Randall Walker; Kathleen A Wannemuehler; John R Wingard; Tom M Chiller; Peter G Pappas
Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010;50(8):1091-100.
2010: Peter G Pappas; Barbara D Alexander; David R Andes; Susan Hadley; Carol A Kauffman; Alison Freifeld; Elias J Anaissie; Lisa M Brumble; Loreen A Herwaldt; James Ito; Dimitrios P Kontoyiannis; G Marshall Lyon; Kieren Marr; Vicki A Morrison; Benjamin Park; Thomas Patterson; Trish M Perl; Robert A Oster; Mindy G Schuster; Randall Walker; THOMAS WALSH; Kathleen A Wannemuehler; Tom M Chiller
Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET).
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010;50(8):1101-11.
2010: George R Thompson; Payal K Patel; William R Kirkpatrick; Steven D Westbrook; Deborah Berg; Josh Erlandsen; Spencer Redding; Thomas Patterson
Oropharyngeal candidiasis in the era of antiretroviral therapy.
Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 2010;109(4):488-95.
2010: Nathan Wiederhold; Laura K Najvar; Rosie Bocanegra; John Graybill; Thomas Patterson
Efficacy of posaconazole as treatment and prophylaxis against Fusarium solani.
Antimicrobial agents and chemotherapy 2010;54(3):1055-9.
2009: Nathan Wiederhold; Christopher R Thornton; Laura K Najvar; William R Kirkpatrick; Rosie Bocanegra; Thomas Patterson
Comparison of lateral flow technology and galactomannan and (1->3)-beta-D-glucan assays for detection of invasive pulmonary aspergillosis.
Clinical and vaccine immunology : CVI 2009;16(12):1844-6.
2009: Georg Maschmeyer; Thomas Patterson
New immunosuppressive agents and risk for invasive fungal infections.
Current infectious disease reports 2009;11(6):435-8.
2009: Jacquelyn Jetton; Juan G Gaviria; Thomas Patterson; Daniel A Johnson
Rifabutin-associated uveitis in an immunocompetent individual with Mycobacterium simiae.
Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 2009;44(4):468-9.
2009: Thomas Patterson; Bonnie T Mackool; Matthew D Gilman; Adriano Piris
Case records of the Massachusetts General Hospital. Case 22-2009. A 59-year-old man with skin and pulmonary lesions after chemotherapy for leukemia [corrected].
The New England journal of medicine 2009;361(3):287-96.
2009: Jose Cadena; George R Thompson; Tony T Ho; edward antonio medina; Darrel W Hughes; Thomas Patterson
Immune reconstitution inflammatory syndrome after cessation of the tumor necrosis factor alpha blocker adalimumab in cryptococcal pneumonia.
Diagnostic microbiology and infectious disease 2009;64(3):327-30.
2009: George R Thompson; Nathan Wiederhold; Deanna A Sutton; Annette W Fothergill; Thomas Patterson
In vitro activity of isavuconazole against Trichosporon, Rhodotorula, Geotrichum, Saccharomyces and Pichia species.
The Journal of antimicrobial chemotherapy 2009;64(1):79-83.
2009: George R Thompson; Jose Cadena; Thomas Patterson
Overview of antifungal agents.
Clinics in chest medicine 2009;30(2):203-15, v.
2009: Justin A Tolman; Nathan Wiederhold; Jason T McConville; Laura K Najvar; Rosie Bocanegra; Jay Peters; Jacqueline J Coalson; John Graybill; Thomas Patterson; Robert O Williams
Inhaled voriconazole for prevention of invasive pulmonary aspergillosis.
Antimicrobial agents and chemotherapy 2009;53(6):2613-5.
2009: E McCulloch; G Ramage; B Jones; P Warn; W R Kirkpatrick; Thomas Patterson; Craig Williams
Don't throw your blood clots away: use of blood clot may improve sensitivity of PCR diagnosis in invasive aspergillosis.
Journal of clinical pathology 2009;62(6):539-41.
2009: M L Herrera; A C Vallor; Jonathan Gelfond; Thomas Patterson; Brian L Wickes
Strain-dependent variation in 18S ribosomal DNA Copy numbers in Aspergillus fumigatus.
Journal of clinical microbiology 2009;47(5):1325-32.
2009: George R Thompson; Michael G Rinaldi; Gennethel Pennick; Sheryl A Dorsey; Thomas Patterson; James S Lewis
Posaconazole therapeutic drug monitoring: a reference laboratory experience.
Antimicrobial agents and chemotherapy 2009;53(5):2223-4.
2009: Sheenu Chandwani; Chuck Wentworth; Thomas A Burke; Thomas Patterson
Utilization and dosage pattern of echinocandins for treatment of fungal infections in US hospital practice.
Current medical research and opinion 2009;25(2):385-93.
2009: Dimitrios P Kontoyiannis; Voravit Ratanatharathorn; J-A Young; J Raymond; M Laverdière; D W Denning; Thomas Patterson; D Facklam; L Kovanda; L Arnold; W Lau; D Buell; Kieren Marr
Micafungin alone or in combination with other systemic antifungal therapies in hematopoietic stem cell transplant recipients with invasive aspergillosis.
Transplant infectious disease : an official journal of the Transplantation Society 2009;11(1):89-93.
2009: Thomas Patterson
Risk stratification for invasive aspergillosis: early assessment of host susceptibility.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2009;47 Suppl 1():S255-60.
2009: George R Thompson; Nathan Wiederhold; Annette W Fothergill; Ana C Vallor; Brian L Wickes; Thomas Patterson
Antifungal susceptibilities among different serotypes of Cryptococcus gattii and Cryptococcus neoformans.
Antimicrobial agents and chemotherapy 2009;53(1):309-11.
2008: George R Thompson; Nathan Wiederhold; Ana C Vallor; Nyria C Villareal; James S Lewis; Thomas Patterson
Development of caspofungin resistance following prolonged therapy for invasive candidiasis secondary to Candida glabrata infection.
Antimicrobial agents and chemotherapy 2008;52(10):3783-5.
2008: Brahm H Segal; Raoul Herbrecht; David A Stevens; Luis Ostrosky-Zeichner; Jack D Sobel; Claudio Viscoli; THOMAS WALSH; Johan Maertens; Thomas Patterson; John R Perfect; Bertrand Dupont; John R Wingard; Thierry Calandra; Carol A Kauffman; John Graybill; Lindsey R Baden; Peter G Pappas; JOHN BENNETT; Dimitrios P Kontoyiannis; Catherine Cordonnier; Maria Anna Viviani; Jacques Bille; Nikolaos G Almyroudis; L Joseph Wheat; Wolfgang Graninger; Eric J Bow; Steven M Holland; Bart Jan Kullberg; William E Dismukes; Ben E De Pauw
Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;47(5):674-83.
2008: George R Thompson; Annette W Fothergill; Nathan Wiederhold; Ana C Vallor; Brian L Wickes; Thomas Patterson
Evaluation of Etest method for determining isavuconazole MICs against Cryptococcus gattii and Cryptococcus neoformans.
Antimicrobial agents and chemotherapy 2008;52(8):2959-61.
2008: Fabrice N Gravelat; Thomas Doedt; Lisa Y Chiang; Hong Liu; Scott Filler; Thomas Patterson; Donald C Sheppard
In vivo analysis of Aspergillus fumigatus developmental gene expression determined by real-time reverse transcription-PCR.
Infection and immunity 2008;76(8):3632-9.
2008: Lisa Y Chiang; Donald C Sheppard; Fabrice N Gravelat; Thomas Patterson; Scott Filler
Aspergillus fumigatus stimulates leukocyte adhesion molecules and cytokine production by endothelial cells in vitro and during invasive pulmonary disease.
Infection and immunity 2008;76(8):3429-38.
2008: Ana C Vallor; William R Kirkpatrick; Laura K Najvar; Rosie Bocanegra; Marsha C Kinney; Annette W Fothergill; Monica L Herrera; Brian L Wickes; John Graybill; Thomas Patterson
Assessment of Aspergillus fumigatus burden in pulmonary tissue of guinea pigs by quantitative PCR, galactomannan enzyme immunoassay, and quantitative culture.
Antimicrobial agents and chemotherapy 2008;52(7):2593-8.
2008: Ben De Pauw; THOMAS WALSH; J Peter Donnelly; David A Stevens; John Edwards; Thierry Calandra; Peter G Pappas; Johan Maertens; Olivier Lortholary; Carol A Kauffman; David W Denning; Thomas Patterson; Georg Maschmeyer; Jacques Bille; William E Dismukes; Raoul Herbrecht; William W Hope; Christopher C Kibbler; Bart Jan Kullberg; Kieren Marr; Patricia Muñoz; Frank C Odds; John R Perfect; Angela Restrepo; Markus Ruhnke; Brahm H Segal; Jack D Sobel; Tania C Sorrell; Claudio Viscoli; John R Wingard; Theoklis Zaoutis; JOHN BENNETT
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;46(12):1813-21.
2008: Laura K Najvar; Rosie Bocanegra; Nathan Wiederhold; C Lambros; N Najarian; Thomas Patterson; John Graybill
Therapeutic and prophylactic efficacy of aminocandin (IP960) against disseminated candidiasis in mice.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2008;14(6):595-600.
2008: George R Thompson; Thomas Patterson
Pulmonary aspergillosis.
Seminars in respiratory and critical care medicine 2008;29(2):103-10.
2008: Erica R Oliveira; Annette W Fothergill; William R Kirkpatrick; Thomas Patterson; Spencer Redding
Antifungal susceptibility testing of micafungin against Candida glabrata isolates.
Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 2008;105(4):457-9.
2008: Nathan Wiederhold; Laura K Najvar; Ana C Vallor; William R Kirkpatrick; Rosie Bocanegra; Destiny Molina; Marcos Olivo; John Graybill; Thomas Patterson
Assessment of serum (1->3)-beta-D-glucan concentration as a measure of disease burden in a murine model of invasive pulmonary aspergillosis.
Antimicrobial agents and chemotherapy 2008;52(3):1176-8.
2008: THOMAS WALSH; Elias J Anaissie; David W Denning; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren Marr; Vicki A Morrison; Brahm H Segal; William J Steinbach; David A Stevens; Jo-Anne H van Burik; John R Wingard; Thomas Patterson
Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;46(3):327-60.
2007: William R Kirkpatrick; Laura K Najvar; Rosie Bocanegra; Thomas Patterson; John Graybill
New guinea pig model of Cryptococcal meningitis.
Antimicrobial agents and chemotherapy 2007;51(8):3011-3.
2007: D Agrawal; Thomas Patterson; M G Rinaldi; Sanjay G Revankar
Trailing end-point phenotype of Candida spp. in antifungal susceptibility testing to fluconazole is eliminated by altering incubation temperature.
Journal of medical microbiology 2007;56(Pt 7):1003-4.
2007: Steven D Westbrook; William R Kirkpatrick; Cesar O Freytes; JUAN TORO; Stella Bernardo; Thomas Patterson; Spencer Redding; Samuel A Lee
Candida krusei sepsis secondary to oral colonization in a hemopoietic stem cell transplant recipient.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2007;45(2):187-90.
2007: Reginald E Greene; Haran T Schlamm; Jörg Oestmann; Paul Stark; Christine Durand; Olivier Lortholary; John R Wingard; Raoul Herbrecht; Patricia Ribaud; Thomas Patterson; Peter Troke; David W Denning; JOHN BENNETT; Ben E de Pauw; Robert Rubin
Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;44(3):373-9.
2007: THOMAS WALSH; Issam Raad; Thomas Patterson; Pranatharthi H Chandrasekar; Gerald R Donowitz; Richard Graybill; Reginald E Greene; Ray Hachem; Susan Hadley; Raoul Herbrecht; Amelia Langston; Arnold Louie; Patricia Ribaud; Brahm H Segal; David A Stevens; Jo-Anne H van Burik; Charles S White; Gavin Corcoran; Jagadish Gogate; Gopal Krishna; Lisa Pedicone; Catherine J Hardalo; John R Perfect
Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;44(1):2-12.
2006: Johan Maertens; Axel Glasmacher; Raoul Herbrecht; Anne Thiebaut; Catherine Cordonnier; Brahm H Segal; John Killar; Arlene Taylor; Nicholas A Kartsonis; Thomas Patterson; Mickael Aoun; Denis Caillot; Carole A Sable
Multicenter, noncomparative study of caspofungin in combination with other antifungals as salvage therapy in adults with invasive aspergillosis.
Cancer 2006;107(12):2888-97.
2006: Thomas Patterson
The role of echinocandins, extended-spectrum azoles, and polyenes to treat opportunistic moulds and Candida.
Current infectious disease reports 2006;8(6):442-8.
2006: David W Denning; Kieren Marr; Wendi M Lau; David P Facklam; Voravit Ratanatharathorn; Cornelia Becker; Andrew J Ullmann; Nita L Seibel; Patricia M Flynn; Jo-Anne H van Burik; Donald N Buell; Thomas Patterson
Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis.
The Journal of infection 2006;53(5):337-49.
2006: Elias J Anaissie; Brahm H Segal; John Graybill; Carola Arndt; John R Perfect; Michael E Kleinberg; Peter Pappas; Danny Benjamin; Robert Rubin; Judith A Aberg; Elisabeth E Adderson; Felice C Adler-Shohet; Hamdi Akan; Murat Akova; Nikolaos G Almyroudis; Barbara D Alexander; David Andes; Antonio Arrieta; John W Baddley; Michelle A Barron; Howard Belzberg; Helen W Boucher; Thomas G Boyce; Arturo Casadevall; Pranatharthi H Chandrasekar; John D Cleary; Catherine Cordonnier; Oliver A Cornely; Manuel Cuenca-Estrella; Jennifer S Daly; Nicholas Daoura; David W Denning; Ben dePauw; Louis de Repentigny; Maria Cecilia Dignani; William E Dismukes; J Peter Donnelly; Gerald R Donowitz; Bertrand Dupont; George L Drusano; Michael Ellis; Ana Espinel-Ingroff; Jay A Fishman; Rhonda Fleming; Graeme Forrest; Mahmoud Ghannoum; Mitchell Goldman; Monica Grazziutti; John N Greene; Richard N Greenberg; Paul O Gubbins; Susan Hadley; Raoul Herbrecht; John W Hiemenz; William Hope; Durane R Hospenthal; Shahid Husain; James I Ito; Robert M Jacobson; Melissa Johnson; Michael R Keating; Daniel H Kett; Katherine Knapp; Dimitrios P Kontoyiannis; Vladimir C Krcmery; Robert Larsen; Michel Laverdiere; Per Ljungman; O Lortholary; Johan Maertens; Debbie Marriott; Gloria Mattiuzzi; Michael R McGinnis; Michele Morris; Marcio Nucci; Frank C Odds; George A Pankey; Thomas Patterson; Mike Pfaller; Raymond R Razonable; Annette C Reboli; Michael G Rinaldi; Glenn D Roberts; Juan Luis Rodriguez Tudela; Coleman Rotstein; Markus Ruhnke; Mindy Schuster; Shmuel Shoham; Irene G Sia; Nita Siebel; Fernanda Silviera; Nina Singh; Jack D Sobel; Joseph S Solomkin; Tania C Sorrell; William J Steinbach; Zelalem Temesgen; AnnaMaria Tortorano; Shahe Vartivarian; Paul VerWeij; Claudio Viscoli; Maria Anna Viviani; Randall C Walker; Joseph L Wheat; Joseph Wiley; Peter R Williamson; John R Wingard; Victor L Yu; Theoklis Zaoutis
Clinical research in the lay press: irresponsible journalism raises a huge dose of doubt.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;43(8):1031-9.
2006: Donald C Sheppard; John Graybill; Laura K Najvar; Lisa Y Chiang; Thomas Doedt; William R Kirkpatrick; Rosie Bocanegra; Ana C Vallor; Thomas Patterson; Scott Filler
Standardization of an experimental murine model of invasive pulmonary aspergillosis.
Antimicrobial agents and chemotherapy 2006;50(10):3501-3.
2006: William J Steinbach; Robert A Cramer; B Zachary Perfect; Yohannes G Asfaw; Theodor C Sauer; Laura K Najvar; William R Kirkpatrick; Thomas Patterson; Daniel K Benjamin; Joseph Heitman; John R Perfect
Calcineurin controls growth, morphology, and pathogenicity in Aspergillus fumigatus.
Eukaryotic cell 2006;5(7):1091-103.
2006: Robert A Cramer; Michael P Gamcsik; Rhea M Brooking; Laura K Najvar; William R Kirkpatrick; Thomas Patterson; Carl J Balibar; John Graybill; John R Perfect; Soman N Abraham; William J Steinbach
Disruption of a nonribosomal peptide synthetase in Aspergillus fumigatus eliminates gliotoxin production.
Eukaryotic cell 2006;5(6):972-80.
2006: William R Kirkpatrick; Brent J Coco; Thomas Patterson
Sequential or combination antifungal therapy with voriconazole and liposomal amphotericin B in a Guinea pig model of invasive aspergillosis.
Antimicrobial agents and chemotherapy 2006;50(4):1567-9.
2005: Mitchell Goldman; Gretchen A Cloud; Karen D Wade; Annette C Reboli; Carl J Fichtenbaum; Richard Hafner; Jack D Sobel; William G Powderly; Thomas Patterson; L Joseph Wheat; David Stein; William E Dismukes; Scott Filler
A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;41(10):1473-80.
2005: Thomas Patterson; Helen W Boucher; Raoul Herbrecht; David W Denning; Olivier Lortholary; Patricia Ribaud; Robert Rubin; John R Wingard; Ben DePauw; Haran T Schlamm; Peter Troke; JOHN BENNETT
Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;41(10):1448-52.
2005: William R Kirkpatrick; Ana C Vallor; Robert K McAtee; Neil S Ryder; Annette W Fothergill; Michael G Rinaldi; Thomas Patterson
Combination therapy with terbinafine and amphotericin B in a rabbit model of experimental invasive aspergillosis.
Antimicrobial agents and chemotherapy 2005;49(11):4751-3.
2005: Thomas Patterson
Advances and challenges in management of invasive mycoses.
Lancet 2005;366(9490):1013-25.
2005: Ben E de Pauw; Thomas Patterson
Should the consensus guidelines' specific criteria for the diagnosis of invasive fungal infection be changed?
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;41 Suppl 6():S377-80.
2005: E R Oliveira; Annette W Fothergill; William R Kirkpatrick; Brent J Coco; Thomas Patterson; Spencer Redding
In vitro interaction of posaconazole and caspofungin against clinical isolates of Candida glabrata.
Antimicrobial agents and chemotherapy 2005;49(8):3544-5.
2005: James S Lewis; Helen W Boucher; Teresa J Lubowski; Ambarish Ambegaonkar; David L Day; Thomas Patterson
Cost advantage of voriconazole over amphotericin B deoxycholate for primary treatment of invasive aspergillosis.
Pharmacotherapy 2005;25(6):839-46.
2005: Thomas Patterson
The future of animal models of invasive aspergillosis.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2005;43 Suppl 1():S115-9.
2004: A K Burn; Annette W Fothergill; William R Kirkpatrick; Brent J Coco; Thomas Patterson; Dora I McCarthy; Michael G Rinaldi; Spencer Redding
Comparison of antifungal susceptibilities to fluconazole and voriconazole of oral Candida glabrata isolates from head and neck radiation patients.
Journal of clinical microbiology 2004;42(12):5846-8.
2004: Johan Maertens; Issam Raad; George Petrikkos; Marc Boogaerts; Dominik Selleslag; Finn B Petersen; Carole A Sable; Nicholas A Kartsonis; Angela Ngai; Arlene Taylor; Thomas Patterson; David W Denning; THOMAS WALSH
Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(11):1563-71.
2004: Spencer Redding; Kieren Marr; William R Kirkpatrick; Brent J Coco; Thomas Patterson
Candida glabrata sepsis secondary to oral colonization in bone marrow transplantation.
Medical mycology : official publication of the International Society for Human and Animal Mycology 2004;42(5):479-81.
2004: Angel Viudes; Anna L Lazzell; Sofia Perea; William R Kirkpatrick; Javier Peman; Thomas Patterson; Jose P Martinez; José L López-Ribot
The C-terminal antibody binding domain of Candida albicans mp58 represents a protective epitope during candidiasis.
FEMS microbiology letters 2004;232(2):133-8.
2004: Spencer Redding; Marta C Dahiya; William R Kirkpatrick; Brent J Coco; Thomas Patterson; Annette W Fothergill; Michael G Rinaldi; Charles Thomas
Candida glabrata is an emerging cause of oropharyngeal candidiasis in patients receiving radiation for head and neck cancer.
Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 2004;97(1):47-52.
2003: Stefano P Bachmann; Gordon Ramage; Kacy VandeWalle; Thomas Patterson; Brian L Wickes; José L López-Ribot
Antifungal combinations against Candida albicans biofilms in vitro.
Antimicrobial agents and chemotherapy 2003;47(11):3657-9.
2003: Marta C Dahiya; Spencer Redding; Rajiv S Dahiya; Tony Y Eng; William R Kirkpatrick; Brent J Coco; Lee C Sadkowski; Annette W Fothergill; Annette Waite; Michael G Rinaldi; Thomas Patterson; Charles Thomas
Oropharyngeal candidiasis caused by non-albicans yeast in patients receiving external beam radiotherapy for head-and-neck cancer.
International journal of radiation oncology, biology, physics 2003;57(1):79-83.
2003: Thomas Patterson
Combination antifungal therapy.
The Pediatric infectious disease journal 2003;22(6):555-6.
2003: Spencer Redding; William R Kirkpatrick; Stephen P Saville; Brent J Coco; William White; Annette W Fothergill; Michael Rinaldi; Tony Y Eng; Thomas Patterson; José L López-Ribot
Multiple patterns of resistance to fluconazole in Candida glabrata isolates from a patient with oropharyngeal candidiasis receiving head and neck radiation.
Journal of clinical microbiology 2003;41(2):619-22.
2002: Thomas Patterson
Early use of antifungal therapy in high-risk patients.
Current opinion in infectious diseases 2002;15(6):561-3.
2002: Kieren Marr; Thomas Patterson; David Denning
Aspergillosis. Pathogenesis, clinical manifestations, and therapy.
Infectious disease clinics of North America 2002;16(4):875-94, vi.
2002: Sofia Perea; Thomas Patterson
Antifungal resistance in pathogenic fungi.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;35(9):1073-80.
2002: Stefano P Bachmann; Kacy VandeWalle; Gordon Ramage; Thomas Patterson; Brian L Wickes; John Graybill; José L López-Ribot
In vitro activity of caspofungin against Candida albicans biofilms.
Antimicrobial agents and chemotherapy 2002;46(11):3591-6.
2002: Marcos Martinez; José L López-Ribot; William R Kirkpatrick; Brent J Coco; Stefano P Bachmann; Thomas Patterson
Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole.
Journal of clinical microbiology 2002;40(9):3135-9.
2002: Sofia Perea; Gloria Gonzalez; Annette W Fothergill; William R Kirkpatrick; Michael G Rinaldi; Thomas Patterson
In vitro interaction of caspofungin acetate with voriconazole against clinical isolates of Aspergillus spp.
Antimicrobial agents and chemotherapy 2002;46(9):3039-41.
2002: Thomas Patterson
New agents for treatment of invasive aspergillosis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;35(4):367-9.
2002: Raoul Herbrecht; David W Denning; Thomas Patterson; JOHN BENNETT; Reginald E Greene; Jörg Oestmann; Winfried V Kern; Kieren Marr; Patricia Ribaud; Olivier Lortholary; Richard Sylvester; Robert Rubin; John R Wingard; Paul Stark; Christine Durand; Denis Caillot; Eckhard Thiel; Pranatharthi H Chandrasekar; Michael R Hodges; Haran T Schlamm; Peter Troke; Ben de Pauw
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.
The New England journal of medicine 2002;347(6):408-15.
2002: William R Kirkpatrick; Sofia Perea; Brent J Coco; Thomas Patterson
Efficacy of caspofungin alone and in combination with voriconazole in a Guinea pig model of invasive aspergillosis.
Antimicrobial agents and chemotherapy 2002;46(8):2564-8.
2002: Nora Cardona-Castro; Sanjay G Revankar; Patricia Ortiz; Claudia Cuervo; William R Kirkpatrick; Robert K McAtee; Thomas Patterson
Proteinase detection, DNA typing and antimycotic susceptibility of Candida isolates from Colombian women with vulvovaginal candidiasis.
Revista iberoamericana de micología 2002;19(2):89-94.
2002: Sofia Perea; Thomas Patterson
Invasive Aspergillus infections in hematologic malignancy patients.
Seminars in respiratory infections 2002;17(2):99-105.
2002: Gordon Ramage; Stefano P Bachmann; Thomas Patterson; Brian L Wickes; José L López-Ribot
Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms.
The Journal of antimicrobial chemotherapy 2002;49(6):973-80.
2002: Stefano P Bachmann; Thomas Patterson; José L López-Ribot
In vitro activity of caspofungin (MK-0991) against Candida albicans clinical isolates displaying different mechanisms of azole resistance.
Journal of clinical microbiology 2002;40(6):2228-30.
2002: Sofia Perea; José L López-Ribot; Brian L Wickes; William R Kirkpatrick; Olga P Dib; Stefano P Bachmann; Suzanne M Keller; Marcos Martinez; Thomas Patterson
Molecular mechanisms of fluconazole resistance in Candida dubliniensis isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.
Antimicrobial agents and chemotherapy 2002;46(6):1695-703.
2002: Marcio Nucci; Tiyomi Akiti; Gloria Barreiros; Fernanda Silveira; Sanjay G Revankar; Brian L Wickes; Deanna A Sutton; Thomas Patterson
Nosocomial outbreak of Exophiala jeanselmei fungemia associated with contamination of hospital water.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;34(11):1475-80.
2002: Spencer Redding; William R Kirkpatrick; Brent J Coco; Lee C Sadkowski; Annette W Fothergill; Michael G Rinaldi; Tony Y Eng; Thomas Patterson
Candida glabrata oropharyngeal candidiasis in patients receiving radiation treatment for head and neck cancer.
Journal of clinical microbiology 2002;40(5):1879-81.
2002: Juergen Loeffler; Kerstin Kloepfer; Holger Hebart; Laura K Najvar; John Graybill; William R Kirkpatrick; Thomas Patterson; Klaus Dietz; Ralf Bialek; Hermann Einsele
Polymerase chain reaction detection of aspergillus DNA in experimental models of invasive aspergillosis.
The Journal of infectious diseases 2002;185(8):1203-6.
2002: M Martínez; José L López-Ribot; William R Kirkpatrick; Stefano P Bachmann; Sofia Perea; María Teresa Ruesga; Thomas Patterson
Heterogeneous mechanisms of azole resistance in Candida albicans clinical isolates from an HIV-infected patient on continuous fluconazole therapy for oropharyngeal candidosis.
The Journal of antimicrobial chemotherapy 2002;49(3):515-24.
2002: William R Kirkpatrick; Sofia Perea; Brent J Coco; Thomas Patterson
Efficacy of ravuconazole (BMS-207147) in a guinea pig model of disseminated aspergillosis.
The Journal of antimicrobial chemotherapy 2002;49(2):353-7.
2002: Thomas Patterson
Fungal susceptibility testing: where are we now?
Transplant infectious disease : an official journal of the Transplantation Society 2002;4 Suppl 3():38-45.
2002: S Ascioglu; John H Rex; Ben E de Pauw; JOHN BENNETT; J Bille; F Crokaert; David W Denning; J Peter Donnelly; John Edwards; Z Erjavec; D Fiere; Olivier Lortholary; Johan Maertens; Jacques Meis; Thomas Patterson; J Ritter; Dominik Selleslag; P M Shah; D A Stevens; THOMAS WALSH
Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;34(1):7-14.
2001: Thomas Patterson
Invasive mycoses: management and unmet medical needs.
Current opinion in infectious diseases 2001;14(6):669-71.
2001: Sofia Perea; José L López-Ribot; William R Kirkpatrick; Robert K McAtee; R A Santillán; M Martínez; D Calabrese; Dominique Sanglard; Thomas Patterson
Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients.
Antimicrobial agents and chemotherapy 2001;45(10):2676-84.
2001: Alan L Lin; Dorthea A Johnson; Thomas Patterson; Yimin Wu; D L Lu; Q Shi; Chih-Ko Yeh
Salivary anticandidal activity and saliva composition in an HIV-infected cohort.
Oral microbiology and immunology 2001;16(5):270-8.
2001: Spencer Redding; C W Bailey; José L López-Ribot; William R Kirkpatrick; Annette W Fothergill; Michael G Rinaldi; Thomas Patterson
Candida dubliniensis in radiation-induced oropharyngeal candidiasis.
Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 2001;91(6):659-62.
2001: Marcio Nucci; Tiyomi Akiti; Gloria Barreiros; Fernanda Silveira; Sanjay G Revankar; Deanna A Sutton; Thomas Patterson
Nosocomial fungemia due to Exophiala jeanselmei var. jeanselmei and a Rhinocladiella species: newly described causes of bloodstream infection.
Journal of clinical microbiology 2001;39(2):514-8.
2001: Gregory M Anstead; James Jorgensen; F Craig; Martin Blaser; Thomas Patterson
Thermophilic multidrug-resistant Campylobacter fetus infection with hypersplenism and histiocytic phagocytosis in a patient with acquired immunodeficiency syndrome.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;32(2):295-6.
2000: William R Kirkpatrick; Robert K McAtee; Annette W Fothergill; Michael G Rinaldi; Thomas Patterson
Efficacy of voriconazole in a guinea pig model of disseminated invasive aspergillosis.
Antimicrobial agents and chemotherapy 2000;44(10):2865-8.
2000: Spencer Redding; William R Kirkpatrick; Olga P Dib; Annette W Fothergill; Michael G Rinaldi; Thomas Patterson
The epidemiology of non-albicans Candida in oropharyngeal candidiasis in HIV patients.
Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry 2000;20(5):178-81.
2000: Thomas Patterson; W R Kirkpatrick; M White; J W Hiemenz; J R Wingard; B Dupont; M G Rinaldi; D A Stevens; John Graybill
Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group.
Medicine 2000;79(4):250-60.
2000: José L López-Ribot; Robert K McAtee; William R Kirkpatrick; Sofia Perea; Thomas Patterson
Comparison of DNA-based typing methods to assess genetic diversity and relatedness among Candida albicans clinical isolates.
Revista iberoamericana de micología 2000;17(2):49-54.
2000: D A Stevens; V L Kan; Marc A Judson; V A Morrison; S Dummer; D W Denning; JOHN BENNETT; THOMAS WALSH; Thomas Patterson; G A Pankey
Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000;30(4):696-709.
2000: Jan Patterson; Jay Peters; John Calhoon; Stephanie M Levine; Antonio Anzueto; Hail M Al-Abdely; R Sanchez; Thomas Patterson; M Rech; James Jorgensen; Michael G Rinaldi; Edward Sako; Scott B Johnson; V Speeg; Glenn A Halff; JK Trinkle
Investigation and control of aspergillosis and other filamentous fungal infections in solid organ transplant recipients.
Transplant infectious disease : an official journal of the Transplantation Society 2000;2(1):22-8.
2000: William R Kirkpatrick; Robert K McAtee; Annette W Fothergill; David Loebenberg; Michael G Rinaldi; Thomas Patterson
Efficacy of SCH56592 in a rabbit model of invasive aspergillosis.
Antimicrobial agents and chemotherapy 2000;44(3):780-2.
2000: William R Kirkpatrick; José L López-Ribot; Robert K McAtee; Thomas Patterson
Growth competition between Candida dubliniensis and Candida albicans under broth and biofilm growing conditions.
Journal of clinical microbiology 2000;38(2):902-4.
1999: Sofia Perea; Thomas Patterson
The role of antifungal susceptibility testing in the management of patients with invasive mycoses.
Revista iberoamericana de micología 1999;16(4):180-6.
1999: Thomas Patterson
Approaches to fungal diagnosis in transplantation.
Transplant infectious disease : an official journal of the Transplantation Society 1999;1(4):262-72.
1999: Thomas Patterson
Role of newer azoles in surgical patients.
Journal of chemotherapy (Florence, Italy) 1999;11(6):504-12.
1999: Spencer Redding; RICHARD ZELLARS; William R Kirkpatrick; Robert K McAtee; M A Caceres; Annette W Fothergill; José L López-Ribot; C W Bailey; Michael G Rinaldi; Thomas Patterson
Epidemiology of oropharyngeal Candida colonization and infection in patients receiving radiation for head and neck cancer.
Journal of clinical microbiology 1999;37(12):3896-900.
1999: Alan L Lin; Q Shi; Dorthea A Johnson; Thomas Patterson; Michael G Rinaldi; Chih-Ko Yeh
Further characterization of human salivary anticandidal activities in a human immunodeficiency virus-positive cohort by use of microassays.
Clinical and diagnostic laboratory immunology 1999;6(6):851-5.
1999: José L López-Ribot; Robert K McAtee; William R Kirkpatrick; R La Valle; Thomas Patterson
Low levels of antigenic variability in fluconazole-susceptible and -resistant Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.
Clinical and diagnostic laboratory immunology 1999;6(5):665-70.
1999: José L López-Ribot; Robert K McAtee; Sofia Perea; William R Kirkpatrick; Michael G Rinaldi; Thomas Patterson
Multiple resistant phenotypes of Candida albicans coexist during episodes of oropharyngeal candidiasis in human immunodeficiency virus-infected patients.
Antimicrobial agents and chemotherapy 1999;43(7):1621-30.
1999: James Jorgensen; J R Salinas; R Paxson; K Magnon; Jan Patterson; Thomas Patterson
False-positive Gen-Probe direct Mycobacterium tuberculosis amplification test results for patients with pulmonary M. kansasii and M. avium infections.
Journal of clinical microbiology 1999;37(1):175-8.
1998: Sanjay G Revankar; Stephen Sanche; Olga P Dib; M Caceres; Thomas Patterson
Effect of highly active antiretroviral therapy on recurrent oropharyngeal candidiasis in HIV-infected patients.
AIDS (London, England) 1998;12(18):2511-3.
1998: John Graybill; Eleanor Marie Montalbo; William R Kirkpatrick; MF Luther; Sanjay G Revankar; Thomas Patterson
Fluconazole versus Candida albicans: a complex relationship.
Antimicrobial agents and chemotherapy 1998;42(11):2938-42.
1998: José L López-Ribot; Robert K McAtee; linda lee; William R Kirkpatrick; T C White; Dominique Sanglard; Thomas Patterson
Distinct patterns of gene expression associated with development of fluconazole resistance in serial candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis.
Antimicrobial agents and chemotherapy 1998;42(11):2932-7.
1998: William R Kirkpatrick; T M Turner; Annette W Fothergill; Dora I McCarthy; Spencer Redding; Michael G Rinaldi; Thomas Patterson
Fluconazole disk diffusion susceptibility testing of Candida species.
Journal of clinical microbiology 1998;36(11):3429-32.
1998: William R Kirkpatrick; Sanjay G Revankar; Robert K McAtee; José L López-Ribot; Annette W Fothergill; Dora I McCarthy; Stephen Sanche; R A Cantu; Michael G Rinaldi; Thomas Patterson
Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar candida screening and susceptibility testing of isolates.
Journal of clinical microbiology 1998;36(10):3007-12.
1998: José L López-Ribot; William R Kirkpatrick; Robert K McAtee; Sanjay G Revankar; Thomas Patterson
Amphotericin B-metronidazole combination against Candida spp.
Revista iberoamericana de micología 1998;15(3):125-30.
1998: Sanjay G Revankar; William R Kirkpatrick; Robert K McAtee; Olga P Dib; Annette W Fothergill; Spencer Redding; Michael G Rinaldi; S G Hilsenbeck; Thomas Patterson
A randomized trial of continuous or intermittent therapy with fluconazole for oropharyngeal candidiasis in HIV-infected patients: clinical outcomes and development of fluconazole resistance.
The American journal of medicine 1998;105(1):7-11.
1998: William R Kirkpatrick; Robert K McAtee; Sanjay G Revankar; Annette W Fothergill; Dora I McCarthy; Michael G Rinaldi; Thomas Patterson
Comparative evaluation of National Committee for Clinical Laboratory Standards broth macrodilution and agar dilution screening methods for testing fluconazole susceptibility of Cryptococcus neoformans.
Journal of clinical microbiology 1998;36(5):1330-2.
1998: Sanjay G Revankar; Olga P Dib; William R Kirkpatrick; Robert K McAtee; Annette W Fothergill; Michael G Rinaldi; Spencer Redding; Thomas Patterson
Clinical evaluation and microbiology of oropharyngeal infection due to fluconazole-resistant Candida in human immunodeficiency virus-infected patients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998;26(4):960-3.
1998: Thomas Patterson
Approaches to therapy for invasive mycoses--the role of amphotericin B.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998;26(2):339-40.
1998: Paul E Verweij; D Poulain; T Obayashi; Thomas Patterson; David W Denning; J Ponton
Current trends in the detection of antigenaemia, metabolites and cell wall markers for the diagnosis and therapeutic monitoring of fungal infections.
Medical mycology : official publication of the International Society for Human and Animal Mycology 1998;36 Suppl 1():146-55.
1998: Sanjay G Revankar; William R Kirkpatrick; Robert K McAtee; Annette W Fothergill; Spencer Redding; Michael G Rinaldi; Thomas Patterson
Interpretation of trailing endpoints in antifungal susceptibility testing by the National Committee for Clinical Laboratory Standards method.
Journal of clinical microbiology 1998;36(1):153-6.
1997: Thomas Patterson; Vincent T Andriole
Detection, significance, and therapy of bacteriuria in pregnancy. Update in the managed health care era.
Infectious disease clinics of North America 1997;11(3):593-608.
1997: Gavin Corcoran; Hail M Al-Abdely; C D Flanders; J Geimer; Thomas Patterson
Markedly elevated serum lactate dehydrogenase levels are a clue to the diagnosis of disseminated histoplasmosis in patients with AIDS.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997;24(5):942-4.
1997: Jan Patterson; A Zidouh; P Miniter; Vincent T Andriole; Thomas Patterson
Hospital epidemiologic surveillance for invasive aspergillosis: patient demographics and the utility of antigen detection.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 1997;18(2):104-8.
1996: Thomas Patterson; William R Kirkpatrick; Sanjay G Revankar; Robert K McAtee; A W Fothergill; Dora I McCarthy; Michael G Rinaldi
Comparative evaluation of macrodilution and chromogenic agar screening for determining fluconazole susceptibility of Candida albicans.
Journal of clinical microbiology 1996;34(12):3237-9.
1996: Elias J Anaissie; Victor L Paetznick; L G Ensign; Ana Espinel-Ingroff; John N Galgiani; C A Hitchcock; M LaRocco; Thomas Patterson; Michael A Pfaller; John H Rex; M G Rinaldi
Microdilution antifungal susceptibility testing of Candida albicans and Cryptococcus neoformans with and without agitation: an eight-center collaborative study.
Antimicrobial agents and chemotherapy 1996;40(10):2387-91.
1996: Sanjay G Revankar; William R Kirkpatrick; Robert K McAtee; Olga P Dib; A W Fothergill; Spencer Redding; Michael G Rinaldi; Thomas Patterson
Detection and significance of fluconazole resistance in oropharyngeal candidiasis in human immunodeficiency virus-infected patients.
The Journal of infectious diseases 1996;174(4):821-7.
1996: Thomas Patterson; Jay Peters; Stephanie M Levine; Antonio Anzueto; C L Bryan; Edward Sako; O L Miller; John Calhoon; Michael G Rinaldi
Systemic availability of itraconazole in lung transplantation.
Antimicrobial agents and chemotherapy 1996;40(9):2217-20.
1996: Thomas Patterson; Sanjay G Revankar; William R Kirkpatrick; Olga P Dib; A W Fothergill; Spencer Redding; Deanna A Sutton; Michael G Rinaldi
Simple method for detecting fluconazole-resistant yeasts with chromogenic agar.
Journal of clinical microbiology 1996;34(7):1794-7.
1996: P K Sharkey; John Graybill; E S Johnson; S G Hausrath; Richard B Pollard; A Kolokathis; Donna Mildvan; P Fan-Havard; R H Eng; Thomas Patterson; J C Pottage; M S Simberkoff; J Wolf; R D Meyer; R Gupta; L W Lee; D S Gordon
Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDS.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1996;22(2):315-21.
1995: Thomas Patterson; P Miniter; Jan Patterson; J M Rappeport; Vincent T Andriole
Aspergillus antigen detection in the diagnosis of invasive aspergillosis.
The Journal of infectious diseases 1995;171(6):1553-8.
1995: David A Fryburg; R J Mark; Bartley P Griffith; P W Askenase; Thomas Patterson
The effect of supplemental beta-carotene on immunologic indices in patients with AIDS: a pilot study.
The Yale journal of biology and medicine 1995;68(1-2):19-23.
1994: Spotswood L Spruance; Andrew T Pavia; D Peterson; A Berry; Richard B Pollard; Thomas Patterson; I Frank; S C Remick; M Thompson; Rodger D MacArthur; G E Morey; C H Ramirez-Ronda; B M Bernstein; D E Sweet; Lawrence R Crane; E A Peterson; C T Pachucki; S L Green; J Brand; A Rios; LM Dunkle; Anne Cross; M J Brown; P Ingraham; R Gugliotti; A H Schindzielorz; L Smaldone
Didanosine compared with continuation of zidovudine in HIV-infected patients with signs of clinical deterioration while receiving zidovudine. A randomized, double-blind clinical trial. The Bristol-Myers Squibb AI454-010 Study Group.
Annals of internal medicine 1994;120(5):360-8.
1993: Thomas Patterson; A W Fothergill; M G Rinaldi
Efficacy of itraconazole solution in a rabbit model of invasive aspergillosis.
Antimicrobial agents and chemotherapy 1993;37(11):2307-10.
1993: T R Frieden; F J Bia; Peter Heald; R N Eisen; Thomas Patterson; Richard L Edelson
Cutaneous cryptococcosis in a patient with cutaneous T cell lymphoma receiving therapy with photopheresis and methotrexate.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1993;17(4):776-8.
1993: D George; D Kordick; P Miniter; Thomas Patterson; Vincent T Andriole
Combination therapy in experimental invasive aspergillosis.
The Journal of infectious diseases 1993;168(3):692-8.
1992: Thomas Patterson; D George; P Miniter; Vincent T Andriole
Saperconazole therapy in a rabbit model of invasive aspergillosis.
Antimicrobial agents and chemotherapy 1992;36(12):2681-5.
1992: Vincent T Andriole; P Miniter; D George; D Kordick; Thomas Patterson
Animal models: usefulness for studies of fungal pathogenesis and drug efficacy in aspergillosis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1992;14 Suppl 1():S134-8.
1992: AM Sugar; E J Anaissie; John Graybill; Thomas Patterson
Fluconazole.
Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology 1992;30 Suppl 1():201-12.
1991: Thomas Patterson; D George; R Ingersoll; P Miniter; Vincent T Andriole
Efficacy of SCH 39304 in treatment of experimental invasive aspergillosis.
Antimicrobial agents and chemotherapy 1991;35(10):1985-8.
1991: Thomas Patterson; D George; P Miniter; Vincent T Andriole
The role of fluconazole in the early treatment and prophylaxis of experimental invasive aspergillosis.
The Journal of infectious diseases 1991;164(3):575-80.
1991: Vincent T Andriole; Thomas Patterson
Epidemiology, natural history, and management of urinary tract infections in pregnancy.
The Medical clinics of North America 1991;75(2):359-73.
1990: Thomas Patterson; Vincent T Andriole; Marcus Zervos; D Therasse; Carol A Kauffman
The epidemiology of pseudallescheriasis complicating transplantation: nosocomial and community-acquired infection.
Mycoses 1990;33(6):297-302.
1990: Thomas Patterson; P Miniter; Vincent T Andriole
Efficacy of fluconazole in experimental invasive aspergillosis.
Reviews of infectious diseases 1990;12 Suppl 3():S281-5.
1989: Jan Patterson; Thomas Patterson; F J Bia; M Barry
Assuring safe travel for today's elderly.
Geriatrics 1989;44(10):44-6, 49-53, 57.
1989: Thomas Patterson; Vincent T Andriole
Current concepts in cryptococcosis.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1989;8(5):457-65.
1989: Jan Patterson; Thomas Patterson; Patricia A Farrel; Walter J Hierholzer; Marcus Zervos
Evaluation of restriction endonuclease analysis as an epidemiologic typing system for Branhamella catarrhalis.
Journal of clinical microbiology 1989;27(5):944-6.
1989: Thomas Patterson; P Miniter; J Dijkstra; Francis Szoka, jr; J L Ryan; Vincent T Andriole
Treatment of experimental invasive aspergillosis with novel amphotericin B/cholesterol-sulfate complexes.
The Journal of infectious diseases 1989;159(4):717-24.
1989: Thomas Patterson; V T Andriole
The role of liposomal amphotericin B in the treatment of systemic fungal infections.
European journal of cancer & clinical oncology 1989;25 Suppl 2():S63-8.
1988: Thomas Patterson; S R Bell; F J Bia
Vibrio alginolyticus cellulitis following coral injury.
The Yale journal of biology and medicine 1988;61(6):507-12.
1988: Thomas Patterson; P Miniter; J L Ryan; Vincent T Andriole
Effect of immunosuppression and amphotericin B on Aspergillus antigenemia in an experimental model.
The Journal of infectious diseases 1988;158(2):415-22.
1988: Thomas Patterson; Jan Patterson; B L Masecar; G E Barden; Walter J Hierholzer; Marcus Zervos
A nosocomial outbreak of Branhamella catarrhalis confirmed by restriction endonuclease analysis.
The Journal of infectious diseases 1988;157(5):996-1001.
1987: Thomas Patterson; Vincent T Andriole
Bacteriuria in pregnancy.
Infectious disease clinics of North America 1987;1(4):807-22.
1987: P M Miniter; Thomas Patterson; M A Johnson; Vincent T Andriole
Activity of LY146032 in vitro and in experimental enterococcal pyelonephritis.
Antimicrobial agents and chemotherapy 1987;31(8):1199-203.